Brainsway (BWAY) Other Non-Current Assets (2018 - 2026)
Brainsway (BWAY) posted quarterly Other Non-Current Assets of $2.3 million for Q1 2026, down 30.16% year-on-year from $3.3 million in Q1 2025, and up 19.42% on a QoQ basis from $1.9 million in Q4 2025.
Brainsway (BWAY) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Other Non-Current Assets for 9 consecutive years, with $2.3 million the latest figure, recorded in Q1 2026.
- Quarterly Other Non-Current Assets fell 30.16% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (down 30.16% YoY) and the FY2025 annual result came in at $1.9 million, down 28.43% from the prior year.
- Other Non-Current Assets grew to $2.3 million in Q1 2026 per BWAY's latest filing, from $1.9 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for BWAY reached as high as $3.9 million in Q2 2025 and fell as low as $863000.0 in Q3 2022.
- A 5-year average of $2.0 million and a median of $1.9 million in 2024 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 498.18% — and 2026, when it plunged 30.16%.
- Year by year, Other Non-Current Assets stood at $1.0 million in 2022, then soared by 64.78% to $1.7 million in 2023, then soared by 57.13% to $2.7 million in 2024, then dropped by 28.43% to $1.9 million in 2025, then climbed by 19.42% to $2.3 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $2.3 million, $1.9 million, and $3.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | 2.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.31 Mn |
| Dec 31, 2025 | 1.93 Mn |
| Sep 30, 2025 | 3.55 Mn |
| Jun 30, 2025 | 3.90 Mn |
| Mar 31, 2025 | 3.30 Mn |
| Dec 31, 2024 | 2.70 Mn |
| Sep 30, 2024 | 2.27 Mn |
| Jun 30, 2024 | 2.05 Mn |
| Mar 31, 2024 | 1.88 Mn |
| Dec 31, 2023 | 1.72 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 1.22 Mn |
| Mar 31, 2023 | 1.06 Mn |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 863,000.00 |
| Jun 30, 2022 | 999,000.00 |
| Mar 31, 2022 | 987,000.00 |
| Dec 31, 2021 | 954,000.00 |
| Sep 30, 2021 | 175,000.00 |
| Jun 30, 2021 | 280,000.00 |